Gilead’s Greed Costs Latin America HIV Protection
AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.
Day: July 9, 2025
AHF accuses Gilead of excluding LAC from access to lenacapavir, forcing secret negotiations after the Global Fund HIV agreement.